DaVita, Inc. engages in the provision of medical care services. The company is headquartered in Denver, Colorado and currently employs 78,000 full-time employees. The firm is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. The company also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
The most recent EPS for DaVita Inc is $3.4, beating expectations of $3.18.
How did DaVita Inc DVA's revenue perform in the last quarter?
DaVita Inc revenue for the last quarter is $3.4
What is the revenue estimate for DaVita Inc?
According to 7 of Wall street analyst, the revenue estimate of DaVita Inc range from $3.65B to $3.39B
What's the earning quality score for DaVita Inc?
DaVita Inc has a earning quality score of B+/54.944733. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does DaVita Inc report earnings?
DaVita Inc next earnings report is expected in 2026-05-03
What are DaVita Inc's expected earnings?
DaVita Inc expected earnings is $3.53B, according to wall-street analysts.
Did DaVita Inc beat earnings expectations?
DaVita Inc recent earnings of $3.61B beat expectations.